Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Communications Biology, 2026
Cross trait analysis reveals shared genetic architecture of eight common female reproductive disorders

Xie Z., Xiong H., Lin Y. et al.

Olink Explore 3072/384GynecologyPathophysiologyPlasma

Journal for ImmunoTherapy of Cancer, 2026
USP1-mediated lipophagy-lipogenesis axis drives cholangiocarcinoma progression and immune evasion

Chen Y., Xu X., Shao S. et al.

Olink Target 96OncologyPathophysiologyCell Lysate

Ecotoxicology and Environmental Safety, 2026
Plasma proteomic signatures of long-term PM2.5 exposure and risk of incident chronic obstructive pulmonary disease

Wang X., Shen Y., Lin Z. et al.

Olink Explore 3072/384Respiratory DiseasesEnvironmental Health & ToxicologyPathophysiologyPlasma

Scientific Reports, 2026
Relating aqueous to vitreous humor proteomics for identification of reliable biomarkers in proliferative diabetic retinopathy

Klaassen I., Tanck M., Duncan H. et al.

Olink Target 96OphthalmologyTechnical EvaluationAqueous HumorVitreous Humor

Communications Medicine, 2026
Multidimensional proteomics and explainable AI feature selection identify cross-platform lung cancer molecular signature in blood plasma

Gushterov N., Hankey L., Kaneva I. et al.

Olink Explore 3072/384OncologyPatient StratificationData ScienceCross-platform ValidationPlasma

Journal for ImmunoTherapy of Cancer, 2026
CD19/CD22 bivalent CAR T cells in children, adolescents and young adults with B-ALL: final phase 1 trial results

Silbert S., Gava F., Yates B. et al.

Olink Target 48OncologyImmunotherapyPathophysiologyPlasma

Neuro-Oncology Advances, 2026
Differential modulation of glioma metabolism and the tumor microenvironment following dexamethasone and bevacizumab treatment

Maise L., Krautwurst F., Surender S. et al.

Olink Target 96OncologyNeurologyPathophysiologyTissue Lysate

The World Journal of Biological Psychiatry, 2026
Dynamical proteomic signatures for depression across preclinical stages in 52,121 individuals from a prospective cohort study

Hui J., Wei W., Chuyu P. et al.

Olink Explore 3072/384NeurologyPatient StratificationPlasma

Frontiers in Immunology, 2026
Large-scale proteome profiling identifies circulating biomarkers for disease activity and organ involvement in ANCA-associated vasculitides

Hellbacher E., Knight A., Hemmingsson P. et al.

Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasmaSerum

Communications Biology, 2026
Early immune events during SARS-CoV-2 infection impact memory T and B cell responses

Woloszczuk K., Joyner D., Connors J. et al.

Olink Target 96Infectious DiseasesPathophysiologyPatient StratificationSerum

ERJ Open Research, 2026
Protracted Lung Repair after Mild Breakthrough Omicron SARS-CoV-2 Infection: “The Storm Beneath the Calm”

Kanth S., Wang H., Tian X. et al.

Olink Explore 3072/384Infectious DiseasesPathophysiologyBALF

Cell, 2026
Plasma signals of lung tumor promotion for molecular cancer prevention

Pandya T., Zagorulya M., Leung M. et al.

Olink Target 96Olink Explore 3072/384OncologyPatient StratificationPlasma

Journal of Cachexia, Sarcopenia and Muscle, 2026
Muscle–Adipose Aging Dynamics and Inflammaging Patterns Across Ethnically Diverse Populations: Exploring Potential Roles of Lipolysis

Hsiao F., Wu J., Chen I. et al.

Olink Explore 3072/384AgingPathophysiologyPlasma

Clinical Medicine, 2026
Frailty phenotype, genetic risk and long-term incident systemic lupus erythematosus risk: Insights from the UK Biobank study integrated with multi-omics analysis

Deng P., Yan S., Lu J.

Olink Explore 3072/384Immunological & Inflammatory DiseasesAgingPathophysiologyPlasma

Cell Death & Differentiation, 2026
Cell death–induced release of the pro-aging protein acyl CoA binding protein (ACBP) into the circulation

Rong Y., Lambertucci F., Yang Y. et al.

Olink Explore 3072/384Metabolic DiseasesPathophysiologyPlasma

Cell Metabolism, 2026
IRG1/itaconate rewires macrophage and lung tumor metabolism through G6PD inhibition

Mansouri S., Hesami G., Ambikan A. et al.

Olink Target 96 MouseOncologyPathophysiologyMouse Tissue Lysate

Clinical and Translational Allergy, 2026
Improvement of Mixed Inflammatory Environment in Nasal Secretions of Diffuse Type 2 Chronic Rhinosinusitis With Nasal Polyps Under Dupilumab

Ryser F., Mauthe T., Brühlmann C. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologySerumNasal Fluid

Cardiovascular Pathology, 2026
A large-scale plasma proteomic study reveals the preclinical evolution and potential biomarkers for coronary atherosclerosis

Wang C., Yan C., Ren Q. et al.

Olink Explore 3072/384CVDPatient StratificationPlasma

Frontiers in Immunology, 2026
Integrative plasma proteomics and myeloid- interferon profiling reveal an AI-validated vascular- endothelial stress signature distinguishing SLE flare from remission in an Indian cohort a discovery – phase study

Karmakar A., Mishra S., Kumar U. et al.

Olink Target 48Immunological & Inflammatory DiseasesPatient StratificationPlasma

iScience, 2026
Angiotensin II prevents the metabolic but not the transdifferentiating effect of EGF on vascular smooth muscle cells from human female donors

Dubourg V., Akhtar N., Kopf M. et al.

Olink Target 96CVDPathophysiologyCell Culture Supernatant

4180 publications